Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue6¢$9.7M
- Other costs84¢$125.8M
- Income tax2¢$3.3M
- Profit8¢$11.3M
Out of $150.1M in revenue.3
Where each dollar of operating cash went, fiscal 2022
- Capital spending0¢$5.9K
- Kept or used elsewhere100¢$1.3M
Out of $1.3M of cash from operations.3
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | $2904 | $150.1M3 | |||||
| Cost of revenue | $584 | $9.7M3 | |||||
| Gross profit | $2324 | $140.4M3 | |||||
| Operating expenses | $4.3K4 | ||||||
| Operating income | -$36.8K5 | -$32.5K6 | -$29.9K7 | -$39.5K8 | -$666.4K4 | -$738.2K3 | $16.1M3 |
| Interest | $15.2K4 | $5.0K3 | $03 | ||||
| Income before tax | -$747.5K4 | ||||||
| Income tax | $3.3M3 | ||||||
| Net income | -$60.7K5 | -$48.2K6 | -$47.8K7 | -$59.9K8 | -$690.9K4 | -$747.5K3 | $11.3M3 |
| Earnings per share | $19,285,714.004 | $20,294,447.004 | |||||
| Shares (weighted, basic) | 20.3M shares3 | 80.2M shares3 | |||||
| Shares (weighted, diluted) | 19.3M shares3 | 80.2M shares3 |
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash | $68.8K4 | $6.2K4 | $285.6K3 | $2.8M3 | |||
| Inventory | $3.1M3 | $1.0M3 | |||||
| Current assets | $4.4K5 | $3.3K6 | $4.0K7 | $4.3K8 | $3.8M4 | $4.6M3 | $50.6M3 |
| Property, plant and equipment | $675.6K3 | $325.6K3 | |||||
| Total assets | $4.4K5 | $3.3K6 | $4.0K7 | $4.3K8 | $13.0M4 | $14.0M3 | $58.6M3 |
| Short-term debt | |||||||
| Current liabilities | $206.4K11 | $283.9K8 | $14.2M4 | $16.3M3 | $43.7M3 | ||
| Total liabilities | $206.4K5 | $218.6K6 | $249.1K7 | $283.9K7 | $14.2M4 | $16.3M3 | $43.7M3 |
| Retained earnings | -$3.2M3 | $8.2M3 | |||||
| Shareholders’ equity | -$202.1K6 | -$215.2K7 | -$245.1K8 | -$279.6K8 | -$1.2M4 | -$2.2M3 | $14.5M3 |
| Shares outstanding | 37.5M shares5 | 38.1M shares6 | 38.1M shares7 | 43.1M shares8 | 19.3M shares4 | 65.3M shares3 | 96.3M shares3 |
What it owns
What Tengjun Biotechnology Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Construction in progress | $7.7M3 Dec 31, 2022 | $8.7M3 Dec 31, 2021 | −11.4% |
| Property and equipment, before depreciation | $1.6M3 Dec 31, 2022 | $1.7M3 Dec 31, 2021 | −8.2% |
| Accumulated depreciation | $1.2M3 Dec 31, 2022 | $1.0M3 Dec 31, 2021 | +20.2% |
| Property and equipment, net | $325.6K3 Dec 31, 2022 | $675.6K3 Dec 31, 2021 | −51.8% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $2.8M3 Dec 31, 2022 | $285.6K3 Dec 31, 2021 | +891.2% |
Inventory
Leadership
Who has led Tengjun Biotechnology Corp., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerQiuping Lu Jul 30, 2014 to Jul 30, 201412
- PresidentQiuping Lu Jul 30, 2014 to Jul 30, 201412
- Chief financial officerQiuping Lu Jun 29, 2012 to Jul 30, 201413
Board members and other officers (5)
- SecretaryFumin Feng Jun 29, 2012 to Jun 29, 201214
- Sole Officer and DirectorNina E. Edstrom Sep 22, 2011 to Jun 29, 201215
- Board memberFumin Feng Jun 29, 2012 to Jun 29, 201214
- Board memberQiuping Lu Jun 29, 2012 to Jul 30, 201413
- Board memberNina E. Edstrom Sep 22, 2011 to Jun 29, 201215
Former names
Timeline
- Nov 17, 20238-K Executive or director change16
- Oct 10, 20238-K Change of auditor17
- Sep 29, 20238-K Executive or director change18
- Sep 21, 20238-K Earlier financial statements no longer reliable; Executive or director change19
- Sep 5, 20238-K Earlier financial statements no longer reliable; Executive or director change20
- Aug 14, 20238-K Earlier financial statements no longer reliable; Executive or director change21
- Aug 7, 20238-K Executive or director change22
- May 8, 20238-K Other events23
- Mar 24, 20238-K Change of auditor24
- Jan 10, 20238-K Other events25
- Sep 2, 20228-K Earlier financial statements no longer reliable26
- Apr 5, 20228-K Other events27
- Jul 30, 2014New chief executive Qiuping Lu becomes CEO12
Filings
44 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 13 major events, 22 other. The latest 20:
- Feb 15, 2024UPLOAD EDGAR
- Jan 25, 2024UPLOAD EDGAR
- Nov 20, 202315-15D EDGAR
- Nov 17, 20238-K CURRENT REPORT EDGAR
- Oct 10, 20238-K CURRENT REPORT EDGAR
- Oct 5, 2023UPLOAD EDGAR
- Sep 29, 20238-K CURRENT REPORT EDGAR
- Sep 21, 2023CORRESP EDGAR
- Sep 21, 20238-K/A AMENDMENT NO. 2 TO FORM 8-K EDGAR
- Sep 7, 2023UPLOAD EDGAR
- Sep 5, 2023CORRESP EDGAR
- Sep 5, 20238-K/A AMENDMENT NO. 1 TO FORM 8-K EDGAR
- Aug 21, 2023UPLOAD EDGAR
- Aug 15, 202310-Q QUARTERLY REPORT EDGAR
- Aug 14, 2023CORRESP EDGAR
- Aug 14, 20238-K CURRENT REPORT EDGAR
- Aug 10, 2023NT 10-Q NOTIFICATION OF LATE FILING EDGAR
- Aug 7, 20238-K CURRENT REPORT EDGAR
- Jul 21, 2023UPLOAD EDGAR
- May 15, 202310-Q QUARTERLY REPORT EDGAR
The 44 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How Tengjun Biotechnology Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARTengjun Biotechnology Corp.1
- CIK0001499785
- Employer ID (EIN)27-30424621
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inNevada1
- Fiscal year endsDecember 311
- Industry code (SIC)2080 Beverages1
- SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance1
- Business addressFood Industry Economic And Technology, Development District, Jining, Shandong, F4 2140281
- Phone86139098407031
- Shares outstanding100,711,196 as of Aug 10, 202310
- Public float$84.7M as of Jun 30, 20223
- On EDGAR sinceSep 16, 20101
- Filings132 in all: 10-Q (38), 8-K (24), 10-K (13), NT 10-Q (8), UPLOAD (8), CORRESP (6), 10-Q/A (4), 3 (4)1
All 20 form types
4 (4), NT 10-K (4), 5 (3), S-1/A (3), SC 13D (3), 8-K/A (2), EFFECT (2), S-1 (2), 10-K/A (1), 15-15D (1), DEF 14C (1), PRE 14C (1)
- Latest filingsAnnual report (10-K) Apr 17, 2023
Quarterly report (10-Q) Aug 15, 2023
Latest 8-K (8-K) Nov 17, 2023
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARQiuping Lu, Chief executive officer
- 13SEC EDGARQiuping Lu, Chief financial officer
- 14SEC EDGARFumin Feng, Secretary
- 15
- 16SEC EDGARExecutive or director change
- 17SEC EDGARChange of auditor
- 18SEC EDGARExecutive or director change
- 19
- 20
- 21
- 22SEC EDGARExecutive or director change
- 23SEC EDGAROther events
- 24SEC EDGARChange of auditor
- 25SEC EDGAROther events
- 26
- 27SEC EDGAROther events